These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 19507862)

  • 1. Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma model.
    Yue EW; Douty B; Wayland B; Bower M; Liu X; Leffet L; Wang Q; Bowman KJ; Hansbury MJ; Liu C; Wei M; Li Y; Wynn R; Burn TC; Koblish HK; Fridman JS; Metcalf B; Scherle PA; Combs AP
    J Med Chem; 2009 Dec; 52(23):7364-7. PubMed ID: 19507862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of potent virtual leads to design novel indoleamine 2,3-dioxygenase inhibitors: pharmacophore modeling and molecular docking studies.
    John S; Thangapandian S; Sakkiah S; Lee KW
    Eur J Med Chem; 2010 Sep; 45(9):4004-12. PubMed ID: 20580138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer disease.
    Macchiarulo A; Camaioni E; Nuti R; Pellicciari R
    Amino Acids; 2009 Jul; 37(2):219-29. PubMed ID: 18612775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The selenazal drug ebselen potently inhibits indoleamine 2,3-dioxygenase by targeting enzyme cysteine residues.
    Terentis AC; Freewan M; Sempértegui Plaza TS; Raftery MJ; Stocker R; Thomas SR
    Biochemistry; 2010 Jan; 49(3):591-600. PubMed ID: 20000778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationship and enzyme kinetic studies on 4-aryl-1H-1,2,3-triazoles as indoleamine 2,3-dioxygenase (IDO) inhibitors.
    Huang Q; Zheng M; Yang S; Kuang C; Yu C; Yang Q
    Eur J Med Chem; 2011 Nov; 46(11):5680-7. PubMed ID: 21925773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exiguamine A, an indoleamine-2,3-dioxygenase (IDO) inhibitor isolated from the marine sponge Neopetrosia exigua.
    Brastianos HC; Vottero E; Patrick BO; Van Soest R; Matainaho T; Mauk AG; Andersen RJ
    J Am Chem Soc; 2006 Dec; 128(50):16046-7. PubMed ID: 17165752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrobenzofurazan derivatives of N'-hydroxyamidines as potent inhibitors of indoleamine-2,3-dioxygenase 1.
    Paul S; Roy A; Deka SJ; Panda S; Trivedi V; Manna D
    Eur J Med Chem; 2016 Oct; 121():364-375. PubMed ID: 27267006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of indoleamine 2,3-dioxygenase in human endometrial carcinoma cells induces rapid tumor growth in a mouse xenograft model.
    Yoshida N; Ino K; Ishida Y; Kajiyama H; Yamamoto E; Shibata K; Terauchi M; Nawa A; Akimoto H; Takikawa O; Isobe K; Kikkawa F
    Clin Cancer Res; 2008 Nov; 14(22):7251-9. PubMed ID: 19010841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and structure-activity relationships of phenyl benzenesulfonylhydrazides as novel indoleamine 2,3-dioxygenase inhibitors.
    Cheng MF; Hung MS; Song JS; Lin SY; Liao FY; Wu MH; Hsiao W; Hsieh CL; Wu JS; Chao YS; Shih C; Wu SY; Ueng SH
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3403-6. PubMed ID: 24939758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel hydroxyamidine derivatives as indoleamine 2,3-dioxygenase 1 inhibitors with in vivo anti-tumor efficacy.
    Liu C; Nan Y; Xia Z; Gu K; Chen C; Dong X; Ju D; Zhao W
    Bioorg Med Chem Lett; 2020 Apr; 30(8):127038. PubMed ID: 32088128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel indoleamine 2,3-dioxygenase-1 inhibitors from a multistep in silico screen.
    Smith JR; Evans KJ; Wright A; Willows RD; Jamie JF; Griffith R
    Bioorg Med Chem; 2012 Feb; 20(3):1354-63. PubMed ID: 22112538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of indoleamine 2,3 dioxygenase activity by H2O2.
    Poljak A; Grant R; Austin CJ; Jamie JF; Willows RD; Takikawa O; Littlejohn TK; Truscott RJ; Walker MJ; Sachdev P; Smythe GA
    Arch Biochem Biophys; 2006 Jun; 450(1):9-19. PubMed ID: 16624246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-affinity uptake of kynurenine and nitric oxide-mediated inhibition of indoleamine 2,3-dioxygenase in bone marrow-derived myeloid dendritic cells.
    Hara T; Ogasawara N; Akimoto H; Takikawa O; Hiramatsu R; Kawabe T; Isobe K; Nagase F
    Immunol Lett; 2008 Feb; 116(1):95-102. PubMed ID: 18179826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of tryptanthrin derivatives as potent inhibitors of indoleamine 2,3-dioxygenase with therapeutic activity in Lewis lung cancer (LLC) tumor-bearing mice.
    Yang S; Li X; Hu F; Li Y; Yang Y; Yan J; Kuang C; Yang Q
    J Med Chem; 2013 Nov; 56(21):8321-31. PubMed ID: 24099220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase.
    Matsuno K; Takai K; Isaka Y; Unno Y; Sato M; Takikawa O; Asai A
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5126-9. PubMed ID: 20688518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and optimization of a novel series of indoleamine 2,3-dioxygenase inhibitors.
    Markwalder JA; Seitz SP; Blat Y; Elkin L; Hunt JT; Pabalan JG; Jure-Kunkel MN; Vite GD; Covello K
    Bioorg Med Chem Lett; 2017 Feb; 27(3):582-585. PubMed ID: 28003141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.
    Ball HJ; Yuasa HJ; Austin CJ; Weiser S; Hunt NH
    Int J Biochem Cell Biol; 2009 Mar; 41(3):467-71. PubMed ID: 18282734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of human indoleamine 2,3-dioxygenase identified with a target-based screen in yeast.
    Vottero E; Balgi A; Woods K; Tugendreich S; Melese T; Andersen RJ; Mauk AG; Roberge M
    Biotechnol J; 2006 Mar; 1(3):282-8. PubMed ID: 16897708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of 5-(N-hydroxycarbamimidoyl) benzofuran derivatives as novel indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
    Jung J; Yoon H; Sohn TI; Jang K; Yoo Y; Jeong I; Shin JE; Lee JH; Ann J; Lee J
    Bioorg Med Chem Lett; 2021 May; 40():127963. PubMed ID: 33741464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of novel tryptoline derivatives as indoleamine 2,3-dioxygenase (IDO) inhibitors.
    Tanaka M; Li X; Hikawa H; Suzuki T; Tsutsumi K; Sato M; Takikawa O; Suzuki H; Yokoyama Y
    Bioorg Med Chem; 2013 Mar; 21(5):1159-65. PubMed ID: 23337802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.